Leukemia and risk of recurrent Escherichia coli bacteremia: genotyping implicates E. coli translocation from the colon to the bloodstream
- PMID: 23649557
- PMCID: PMC3824565
- DOI: 10.1007/s10096-013-1886-9
Leukemia and risk of recurrent Escherichia coli bacteremia: genotyping implicates E. coli translocation from the colon to the bloodstream
Abstract
In patients with leukemia, the portal(s) and reasons for the persistence of an Escherichia coli recurrent bacteremia remain unclear. Adult Hematology Clinic (AHC) databases at the State Clinical Hospital in Gdańsk were reviewed to evaluate the frequency of E. coli bacteremia between 2002 and 2005. Blood and bowel E. coli strains were obtained and the genetic relatedness of the strains was analyzed. The rate of E. coli bacteremia per 1,000 admissions at the AHC was higher (85.0) than in the other clinics of the hospital (2.9), p < 0.001. A higher mortality was observed in patients with a history of E. coli versus non-E. coli bacteremia [30/95 (31 %) vs. 53/430 (12 %), p < 0.001]; 72.8 % of patients with leukemia had an unknown source of bacteremia. In 2005, 6 out of 25 (24 %) patients with leukemia had ≥2 episodes of E. coli-positive blood cultures. These gastrointestinal E. coli isolates were replaced within 3-8 weeks with a new E. coli H genotype. A recurrent episode of bacteremia was usually caused by an infection with a transient E. coli H genotype identical to that found in the subject's bowel. Consistent with the definition of bowel/blood translocation, the bowel appeared to be a portal for E. coli in these subjects and, hence, a clear source for their recurring bacteremia.
Figures


Similar articles
-
Bacteremias caused by Escherichia coli in cancer patients - analysis of 65 episodes.Int J Infect Dis. 2002 Mar;6(1):69-73. doi: 10.1016/s1201-9712(02)90140-2. Int J Infect Dis. 2002. PMID: 12044306
-
Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes.Int J Antimicrob Agents. 2017 Apr;49(4):498-502. doi: 10.1016/j.ijantimicag.2016.12.013. Epub 2017 Feb 28. Int J Antimicrob Agents. 2017. PMID: 28257756
-
Characterisation of Escherichia coli isolates from the blood of haematological adult patients with bacteraemia: translocation from gut to blood requires the cooperation of multiple virulence factors.Eur J Clin Microbiol Infect Dis. 2015 Jun;34(6):1135-43. doi: 10.1007/s10096-015-2331-z. Epub 2015 Feb 6. Eur J Clin Microbiol Infect Dis. 2015. PMID: 25655758 Free PMC article.
-
[Escherichia coli a forgotten pathogen in septicemia].Przegl Epidemiol. 2006;60(1):27-34. Przegl Epidemiol. 2006. PMID: 16758735 Polish.
-
Molecular epidemiological analysis of quinolone-resistant Escherichia coli causing bacteremia in neutropenic patients with leukemia in Korea.Clin Infect Dis. 1997 Dec;25(6):1385-91. doi: 10.1086/516132. Clin Infect Dis. 1997. PMID: 9431383 Review.
Cited by
-
The Many Faces of Enterococcus spp.-Commensal, Probiotic and Opportunistic Pathogen.Microorganisms. 2021 Sep 7;9(9):1900. doi: 10.3390/microorganisms9091900. Microorganisms. 2021. PMID: 34576796 Free PMC article. Review.
-
Safety and tolerability of frozen, capsulized autologous faecal microbiota transplantation. A randomized double blinded phase I clinical trial.PLoS One. 2023 Sep 27;18(9):e0292132. doi: 10.1371/journal.pone.0292132. eCollection 2023. PLoS One. 2023. PMID: 37756322 Free PMC article. Clinical Trial.
-
Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria.Haematologica. 2019 Aug;104(8):1682-1688. doi: 10.3324/haematol.2018.198549. Epub 2019 Feb 7. Haematologica. 2019. PMID: 30733264 Free PMC article.
-
Risk factors and microbiological features of recurrent Escherichia coli bloodstream infections.PLoS One. 2023 Jan 10;18(1):e0280196. doi: 10.1371/journal.pone.0280196. eCollection 2023. PLoS One. 2023. PMID: 36626405 Free PMC article.
-
Evaluation of antibiotic resistance, toxin-antitoxin systems, virulence factors, biofilm-forming strength and genetic linkage of Escherichia coli strains isolated from bloodstream infections of leukemia patients.BMC Microbiol. 2023 Nov 4;23(1):327. doi: 10.1186/s12866-023-03081-8. BMC Microbiol. 2023. PMID: 37925405 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical